$1.41
+0.05 (+3.68%)
Open$1.38
Previous Close$1.36
Day High$1.43
Day Low$1.36
52W High$2.89
52W Low$1.15
Volume—
Avg Volume2.78M
Market Cap375.84M
P/E Ratio—
EPS$-0.06
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,045.4% upside
Current
$1.41
$1.41
Target
$16.15
$16.15
$10.52
$16.15 avg
$19.28
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 977.58M | 889.20M | 59.12M |
| Net Income | -16,286,401 | -13,332,509 | 16.50M |
| Profit Margin | -1.7% | -1.6% | 27.9% |
| EBITDA | 41.26M | 35.66M | 25.74M |
| Free Cash Flow | — | — | 14.78M |
| Rev Growth | +9.9% | +9.9% | +13.8% |
| Debt/Equity | 0.15 | 0.15 | 0.23 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |